Simpa S Salami, MD, MPH

Simpa Salami
David A Bloom Professor of Urology
Associate Professor of Urology
Rogel Cancer Center Associate Director, Medical School
Available to mentor
Simpa S Salami, MD, MPH
Simpa Salami
Associate Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation.

    Links

    • Urology Department Profile
    • twitter
    • linkedin

    Qualifications

    • Innovation Nexus Bootcamp
      American Urological Association, Linthicum, Maryland, United States
      2023 - 2023
    • MPH
      Harvard University School of Public Health, 677 Huntington Ave, Boston, Massachusetts, 02215, United States
      2008 - 2009
    • MD
      University of Ibadan, College of Medicine, Ibadan, Oyo State, Nigeria, Nigeria
      2000 - 2006

    Center Memberships

    • Center Member
      Taubman Institute
    • Center Member
      AI and Digital Health Innovation
    • Center Member
      Rogel Cancer Center
    • Center Member
      Center for Global Health Equity
    • Center Member
      Global REACH

    Research Overview

    My research focuses on improving the early detection and treatment of prostate and kidney cancers through the discovery of novel actionable biomarkers. By integrating sophisticated molecular profiling and computational approaches, my lab aims to refine risk stratification, predict treatment response, and develop personalized medicine strategies to improve urologic cancer outcomes.

    Recent Publications

    See All Publications
    • Journal Article
      Reply: Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison With MRI.
      Tosoian JJ, Penson DF, Ross AE, Salami SS, Meyers JI, Chinnaiyan AM. J Urol, 2026 Oct 15; 101097JU0000000000005332 DOI:10.1097/JU.0000000000005332
      PMID: 42879247
    • Journal Article
      Darolutamide associé à une suppression androgénique (ADT) dans le cancer de la prostate métastatique hormono-sensible (CPHSm) : ARASEC – Étude prospective de phase II en ouvert avec un bras contrôle externe
      Rozet F, Mckay RR, Ross AE, Preston MA, Gregg JR, Salami SS, Saad F, Pieczonka CM, Tutrone RF, Hamilton J, Morris DS, Belkoff LH, Lance RS, Littleton N, Constantinovici N, Srinivasan S, Verholen F, Shore ND. Progrès en Urologie - FMC, 2026 Oct 31; 36 (7): s24 - s25. DOI:10.1016/j.fpurol.2026.07.038
    • Preprint
      Tumor-adjacent B cell infiltration stratifies recurrence risk in localized prostate cancer.
      Wang B, Mukherjee S, Baj A, Trostel SY, Lis RT, Whitlock NC, Ku AT, Heyward KE, Kartal S, Wang K, Voznesensky OS, Calagua C, Siddiqui J, Martin RS, Kollath LA, Custer J, Michael PD, Kunju LP, Lake R, Harris CC, Aldape KD, True LD, Tatsuoka C, Fertig EJ, Chinnaiyan A, Gurram S, Pinto PA, Weiner AB, Morrissey C, Salami SS, Einstein DJ, Balk SP, Sowalsky AG, Ruppin E. 2026 Aug 31; DOI:10.64898/2026.08.29.26361718
      PMID: 42922617
    • Journal Article
      Is Gleason pattern 3 cancer? Molecular features do not distinguish pattern 3 from benign tissue
      Leni R, Eggener SE, Cooperberg MR, Salami SS, Weiner AB, Zhou M, Al-Sattar H, Lamb AD, Vickers AJ. BJU International, 2026 Jan 1; DOI:10.1111/bju.70433
      PMID: 42750341
    • Journal Article
      Risk-stratified Prostate Cancer Screening in 2026: Blood- and Urine-based Biomarkers
      Stangl-Kremser J, Salami SS. European Urology Focus, 2026 Jan 1; DOI:10.1016/j.euf.2026.10.007

    Featured News & Stories

    Department News

    Endowed Professorship Ceremony

    Three outstanding Urology faculty were honored with endowed professorships, recognizing their leadership, achievements, and lasting contributions to research, education, and patient care.
    Department News

    Medical School Honors Three Faculty Members with Endowed Professorships

    The University of Michigan Medical School celebrates Dr. Salami, Dr. Kraft and Dr. Gupta on receiving endowed professorships, one of the institution’s highest faculty honors.
    Michigan Urology Global Health Rwanda
    Department News

    Michigan Urology Global Health Update

    Drs. Efe Chantal Simons, Priyanka Gupta, and Stephanie Kielb visited Rwanda in May for a surgical mission focused on treating obstetric fistula.
    light lights seen on dark navy screen
    Health Lab

    Researchers identify novel biomarker linked to renal cancer recurrence

    Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence.
    Department News

    Racial Disparities in Prostate Cancer and Skin Cancer

    Weiser Center for Prostate Cancer and Michigan Medicine host event where health experts and patients tackle issue of equitable prostate cancer and skin cancer screening and treatment